Enzolytics Inc.

Enzolytics Inc.

ENZC - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.38M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Enzolytics Inc.Enzolytics Inc.-14.9-0%--2.2
$-0.00

Current Fair Value

175% downside

Overvalued by 175% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1.38 Million
Enterprise Value$261.06 Million
Earnings per Share$0
Beta0.51
Outstanding Shares3,444,470,933

Return

Return on Equity0.34%ROE
Return on Assets-0.20%
Return on Invested Capital0.31%

Valuation & Multiples

P/E Ratio-14.94P/E Ratio
PEG-0.3PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-711.11
Enterprise Value to Net Income-647
Total Debt to Enterprise0.99
Debt to Equity-2.19Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Enzolytics Inc.

1 employees
CEO: Steven Sharabura

Enzolytics Inc., a biopharmaceutical company based in Plano, Texas, is dedicated to the development and commercialization of its specialized protein-based therapies. Its primary focus is on addressing severe infectious illnesses. The com...